NCT02351518

Brief Summary

Traumatic brain injury (TBI) affects 1.5 million patients per year in the United States, resulting in more than 50,000 deaths and more than 230,000 hospitalizations annually. Approximately 90,000 of these patients will suffer permanent impairment and more than half will experience short-term disability. Secondary injury processes play a critical role in the development of ischemia after trauma to the central nervous system and occur hours-to-days after the primary insult. Ischemia can lead to cerebral infarction or stroke. Ischemia has been described as the single most important secondary insult and has been identified histologically in approximately 90% of patients who die following closed head injury. Several factors resulting in post-traumatic cerebral ischemia have been identified: increased intracranial pressure (ICP), systemic arterial hypotension, and cerebral vasospasm. Cerebral vasospasm has been described as a sustained arterial narrowing. Clinically, the onset of new or worsening neurological symptoms is the most reliable indicator of cerebral vasospasm following a ruptured cerebral aneurysm. However, cerebral vasospasm is often unrecognized in patients suffering from moderate to severe TBI. These patients frequently have altered mental status due to the primary brain injury. In addition, they require narcotics for their pain and paralytics and/or sedatives while on a mechanical ventilator for airway protection. Thus, relying on the neurological exam to observe deteriorating neurological signs consistent with post-traumatic vasospasm (PTV) is reliable. While the etiology and outcome of patients with vasospasm secondary to ruptured aneurysm is well documented, the clinical significance of PTV after TBI is unknown. A better understanding of the role of cerebral autoregulation in the development of cerebral vasospasm could provide the answer. This proposal is for a pilot observational study describing the association of the impairment of cerebral autoregulation as measured by near infrared spectroscopy (NIRS) with the development of clinically significant vasospasm in patients with moderate to severe TBI. The information will serve as preliminary data for further study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 30, 2015

Completed
9 months until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2017

Completed
Last Updated

January 27, 2022

Status Verified

January 1, 2022

Enrollment Period

1.7 years

First QC Date

January 19, 2015

Last Update Submit

January 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional Outcome as assessed by the Glasgow Functional Outcome-Extended

    within 12 months post hospital discharge

Secondary Outcomes (2)

  • Mortality

    within 30 days

  • Hospital Length of Stay

    within 60 days

Interventions

There will be no interventions in this study

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients aged 15 years and older, presenting with a motor score of \<6 and thought to have TBI due to a mechanism of injury, will undergo screening with head computed tomography (CT). Admission CT will be interpreted by an attending radiologist to determine Head Abbreviated Injury Score (AIS) score. If the AIS score by CT is \> 2, the patient will be eligible for the study. Patients determined by neurosurgery to have a non-survivable TBI on admission will be excluded given the poor likelihood of completion of the study protocol.

You may qualify if:

  • years of age and greater
  • Motor Glasgow Coma Score (GCS) \< 6 within approximately 24 hours of admission
  • Head AIS \> 2

You may not qualify if:

  • Motor GCS \>5
  • Determination of non-survivability on admission
  • Non-English speakers
  • Prisoners that are on parole or probation
  • Active duty military
  • Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

R Adams Cowley Shock Trauma Center, University of Maryland Medical Center

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticBrain IschemiaCerebral Infarction

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesBrain InfarctionStrokeInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Deborah Stein, MD, MPH

    Professor of Surgery, Department of Surgery, Chief of Trauma R Adams Cowley Shock Trauma Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Surgery, University of Maryland , Chief of Trauma R Adams Cowley Shock Trauma Center

Study Record Dates

First Submitted

January 19, 2015

First Posted

January 30, 2015

Study Start

November 1, 2015

Primary Completion

June 30, 2017

Study Completion

June 30, 2017

Last Updated

January 27, 2022

Record last verified: 2022-01

Locations